Maximizing Surgical Outcomes With New Target-Specific Therapies

References: 1. Balfour IA, Lamb HM. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 2000:59:115-139.2. Schedletzky H, Wiedemann B, Heisig f. The effect of moxifloxacin on its target topoisomerases from Escherichia colt and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology Times 2006-03, Vol.31 (6), p.S1
Format:	Artikel
Sprache:	eng
Schlagworte:	Accreditation Antibiotics Appointments & personnel changes Blindness Cataracts Clinical outcomes Conflicts of interest Disclosure Educational objectives Executives Eye surgery Health risk assessment Infections Inflammation Laboratories Learning activities Medical education Medicine Nonsteroidal anti-inflammatory drugs Ophthalmology Pharmaceuticals Surgical outcomes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	References: 1. Balfour IA, Lamb HM. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 2000:59:115-139.2. Schedletzky H, Wiedemann B, Heisig f. The effect of moxifloxacin on its target topoisomerases from Escherichia colt and Slaptyiocoaus aurais. J Antimicrob Chemother. 1999;43 Suppl B:31 -37.3.Tankovic I, Bachoual R, Ouabdesselam S, Boudjadja A.
ISSN:	0193-032X 2150-7333